GO:1904426 positive regulation of GTP binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904426 (positive regulation of GTP binding) is a biological process that increases the frequency, rate, or extent of GTP binding to a protein.
• GTP binding is essential for the function of small GTPases, heterotrimeric G-proteins, and many other regulatory proteins, controlling processes such as signal transduction, membrane trafficking, and cytokinesis [1, 6, 8].
• Positive regulation can occur through mechanisms such as GTPase activating protein (GAP) inhibition, guanine nucleotide exchange factor (GEF) activation, or stabilization of the GTP-bound conformation [1, 2].
• Dysregulation of GTP binding is linked to cancer, neurodegeneration, and developmental disorders, making it a target for therapeutic intervention [2, 5, 7].
• CRISPR-based knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect the causal roles of genes involved in positive regulation of GTP binding [6, 8].
• Studying this process requires a combination of biochemical assays, imaging, and omics approaches to measure GTP binding and downstream effects [1, 4, 8].
Description
Positive regulation of GTP binding (GO:1904426) is a biological process that activates or increases the frequency, rate, or extent of GTP binding to a protein. GTP binding is a fundamental molecular event that switches many proteins into their active state, enabling them to transmit signals, remodel membranes, or drive mechanical forces within cells [1, 8]. This process is critical for the proper functioning of small GTPases such as Ras, Rho, Rab, and Ran, as well as heterotrimeric G-proteins and various GTP-binding proteins involved in translation and cytoskeletal dynamics [1, 5, 8]. Researchers study positive regulation of GTP binding to understand how cells control signal transduction, vesicle trafficking, cell division, and responses to environmental cues [1, 6, 8]. Dysregulation of this process contributes to diseases including cancer, neurodegeneration, and developmental disorders, highlighting its biomedical importance [2, 5, 7].
positive regulation of GTP binding At A Glance
| GO ID | GO:1904426 |
|---|---|
| GO term | positive regulation of GTP binding |
| Ontology | biological_process |
| Synonym | activation of GTP binding, up regulation of GTP binding, up-regulation of GTP binding, upregulation of GTP binding |
| Definition | Any process that activates or increases the frequency, rate or extent of GTP binding. |
| Major function | Enhances the active, GTP-bound state of GTPases and other GTP-binding proteins, thereby promoting downstream signaling, trafficking, and mechanical processes. |
| Related processes | GTPase activity, signal transduction, membrane trafficking, cytokinesis, protein synthesis. |
| Key regulators | Guanine nucleotide exchange factors (GEFs), GTPase activating proteins (GAPs), and accessory proteins. |
| Disease relevance | Cancer, neurodegeneration, developmental disorders, and immune dysfunction. |
What Is GO:1904426?
According to the Gene Ontology, GO:1904426 (positive regulation of GTP binding) is defined as any process that activates or increases the frequency, rate, or extent of GTP binding. In other words, it encompasses molecular events that promote the association of GTP with a target protein, often by enhancing the exchange of GDP for GTP, inhibiting GTP hydrolysis, or stabilizing the GTP-bound state [1, 2]. This regulation can be mediated by guanine nucleotide exchange factors (GEFs), GTPase activating proteins (GAPs), or other modulatory proteins that directly or indirectly affect the nucleotide-binding status of GTPases [1, 2].
Why Is positive regulation of GTP binding Important in Cell Biology?
Positive regulation of GTP binding is crucial because it controls the activation of a vast array of GTP-binding proteins that act as molecular switches in nearly every cellular process [1, 8]. By promoting GTP binding, cells can rapidly and reversibly activate signaling cascades, direct vesicle transport, and coordinate cell division [1, 6, 8]. Understanding this process provides insights into fundamental cell biology and offers therapeutic opportunities for diseases where GTPase signaling is perturbed [2, 5, 7].
• Controls the activation of small GTPases such as Ras, Rho, Rab, and Ran, which regulate cell proliferation, cytoskeletal dynamics, and nuclear transport [1, 5, 8].
• Essential for heterotrimeric G-protein signaling in response to hormones and neurotransmitters.
• Regulates membrane trafficking and organelle identity through Rab GTPases.
• Required for cytokinesis and cell division, as shown for anillin and its regulation by importin.
• Involved in the cellular response to oxidative stress via nucleostemin and other GTP-binding proteins.
• Plays a role in plant development and brassinosteroid signaling, as demonstrated for DEP1 in rice.
• Dysregulation is linked to cancer, neurodegeneration, and developmental disorders [2, 5, 7].
• Provides targets for drug discovery, particularly for cancers driven by mutant GTPases [2, 5].
• Helps understand bacterial flagellar biogenesis and motility.
• Facilitates the study of mitophagy and Parkinson's disease through RAB7A and Parkin.
What Happens During positive regulation of GTP binding?
Nucleotide Exchange and GEF Activation
In simple terms: Helper proteins called GEFs help GTP-binding proteins swap GDP for GTP, turning them on.
The primary mechanism for positive regulation of GTP binding is the acceleration of GDP-to-GTP exchange, typically mediated by guanine nucleotide exchange factors (GEFs). GEFs bind to the inactive, GDP-bound form of a GTPase and catalyze the release of GDP, allowing the more abundant GTP to bind. This process is highly regulated and specific, ensuring that the correct GTPase is activated at the right time and place. For example, in GPCR signaling, GEFs are not typically involved; instead, ligand-bound receptors act as GEFs for heterotrimeric G-proteins, promoting GTP binding to the Gα subunit.
Inhibition of GTP Hydrolysis
In simple terms: Blocking the GTPase's ability to break down GTP keeps it active longer.
Another way to positively regulate GTP binding is by inhibiting GTP hydrolysis, which prolongs the lifetime of the active GTP-bound state. This can occur through the action of GTPase activating proteins (GAPs) that are themselves inhibited, or through post-translational modifications that impair the intrinsic GTPase activity [1, 2]. For instance, phosphorylation of RAB7A can modulate its interaction with Rubicon Homology proteins, affecting Parkin-dependent mitophagy.
Stabilization of the GTP-Bound Conformation
In simple terms: Some proteins lock the GTP-bound form in place, preventing it from turning off.
Accessory proteins can bind to GTPases and stabilize the GTP-bound conformation, effectively increasing the amount of GTP-bound protein. For example, developmentally regulated GTP-binding protein 2 (DRG2) is required for stabilization of Rac1-positive membrane tubules, suggesting a role in maintaining Rac1 in its active state. Similarly, nucleostemin oligomerization regulated by reactive oxygen species may influence its GTP binding and stability.
Spatiotemporal Regulation by Scaffolds and Localization
In simple terms: Where and when a GTPase is located affects whether it binds GTP.
Positive regulation of GTP binding is often spatially restricted by scaffold proteins and membrane localization [6, 8]. For example, anillin, a cytoskeletal protein, undergoes intramolecular regulation by importin binding, which affects its interaction with RhoA and its role in cytokinesis. Ral GTPases mediate membrane trafficking, and their activation is tightly controlled by localization to specific membranes.
Integration with Cellular Signals
In simple terms: External signals can trigger GTP binding to coordinate cellular responses.
Signals from growth factors, hormones, and stress can lead to positive regulation of GTP binding [1, 3, 7]. In rice, the G-protein γ subunit DEP1 facilitates brassinosteroid signaling via a MYB-bHLH-ARF module, demonstrating how GTP binding is integrated into developmental pathways. In bacteria, flagellar biogenesis is regulated by GTP binding to FlhF and FlhG, controlling the number and placement of flagella.
Key Genes Involved in GO:1904426 positive regulation of GTP binding
The following genes and proteins are key players in the positive regulation of GTP binding, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HRAS | Small GTPase involved in cell proliferation and differentiation; activated by GTP binding. | Mutations cause cancer; model for studying GEF/GAP regulation. |
| RAB7A | Late endosomal GTPase; regulates mitophagy and endocytic trafficking. | Phosphoswitch controls Parkin-dependent mitophagy; target for neurodegeneration. |
| DEP1 | G-protein γ subunit in rice; facilitates brassinosteroid signaling. | Model for plant G-protein signaling and crop improvement. |
| FlhF | GTP-binding protein regulating flagellar biogenesis. | Bacterial motility and pathogenesis studies. |
| DRG2 | Developmentally regulated GTP-binding protein; stabilizes Rac1-positive membrane tubules. | Role in cell migration and membrane dynamics. |
| ANLN | Anillin; actin-binding protein regulated by importin and RhoA. | Cytokinesis and cancer research. |
| GNL3 | Nucleostemin; GTP-binding protein involved in ribosome biogenesis and stem cell maintenance. | Regulated by ROS; implicated in cancer and aging. |
| RALA | Ral GTPase; mediator of membrane trafficking. | Role in exocytosis and tumorigenesis. |
| RALB | Ral GTPase; mediator of membrane trafficking. | Role in exocytosis and tumorigenesis. |
| RHOA | Small GTPase regulating cytoskeleton and cytokinesis. | Target for cancer and metastasis studies. |
| RAC1 | Small GTPase regulating membrane ruffling and migration. | Stabilized by DRG2; role in cancer. |
| GNAI1 | Heterotrimeric G-protein α subunit; binds GTP upon receptor activation. | GPCR signaling research. |
| GNAI2 | Heterotrimeric G-protein α subunit; binds GTP upon receptor activation. | GPCR signaling research. |
| GNAI3 | Heterotrimeric G-protein α subunit; binds GTP upon receptor activation. | GPCR signaling research. |
| GNAS | Heterotrimeric G-protein α subunit; stimulates adenylyl cyclase. | Disease mutations (e.g., McCune-Albright). |
| GNAQ | Heterotrimeric G-protein α subunit; involved in GPCR signaling. | Uveal melanoma and other cancers. |
| GNA11 | Heterotrimeric G-protein α subunit; involved in GPCR signaling. | Uveal melanoma and other cancers. |
| GNA12 | Heterotrimeric G-protein α subunit; involved in GPCR signaling. | Cancer and fibrosis research. |
How Is positive regulation of GTP binding Regulated?
Positive regulation of GTP binding is itself tightly regulated by upstream signals and feedback loops. For example, GPCR signaling is dually regulated by GTP hydrolysis, which acts as a timer to turn off the signal. GEFs and GAPs are controlled by phosphorylation, lipid binding, and protein-protein interactions [1, 2]. In plants, DEP1 integrates brassinosteroid signals to modulate GTP binding. Reactive oxygen species can regulate nucleostemin oligomerization and degradation, affecting its GTP-binding capacity. Additionally, importin binding regulates anillin during cytokinesis, linking nuclear transport to GTPase regulation.
positive regulation of GTP binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HRAS | Cancer (e.g., bladder, lung, thyroid) | Knockout and point mutation (G12V) in cancer cell lines |
| RAB7A | Parkinson's disease, Charcot-Marie-Tooth disease | Knock-in of phosphomimetic or phosphodeficient mutants in neurons |
| GNAS | McCune-Albright syndrome, pseudohypoparathyroidism | Knock-in of activating mutations in mice |
| DEP1 | Plant architecture and yield | Knockout and overexpression in rice |
| DRG2 | Cell migration and membrane dynamics | Knockout in mammalian cells |
Cancer
Dysregulation of GTP binding is a hallmark of many cancers. Mutations in RAS genes (HRAS, KRAS, NRAS) impair GTP hydrolysis, leading to constitutive GTP binding and uncontrolled proliferation. Similarly, mutations in GNAQ and GNA11 are found in uveal melanoma. Ral GTPases (RALA, RALB) are effectors of Ras and contribute to tumorigenesis and metastasis. Targeting the positive regulation of GTP binding, such as by inhibiting GEFs or stabilizing GAPs, is a therapeutic strategy [1, 2].
Neurodegeneration
RAB7A is critical for mitophagy, and its dysregulation is linked to Parkinson's disease. The phosphoswitch on RAB7A coordinates Rubicon Homology protein regulation of Parkin-dependent mitophagy, and defects in this pathway lead to accumulation of damaged mitochondria and neurodegeneration. Nucleostemin (GNL3) is involved in ribosome biogenesis and stem cell maintenance, and its dysregulation may contribute to aging and neurodegenerative conditions.
Developmental Disorders
GTP-binding proteins play essential roles in development. In rice, DEP1 regulates brassinosteroid signaling and plant architecture. In humans, mutations in GNAS cause McCune-Albright syndrome and other developmental disorders. DRG2 is required for stabilization of Rac1-positive membrane tubules, which are important for cell migration and tissue morphogenesis.
Infectious Diseases
Bacterial flagellar biogenesis, regulated by GTP-binding proteins like FlhF, is essential for motility and pathogenesis. Understanding how GTP binding is positively regulated in bacteria could lead to new antibiotics.
From positive regulation of GTP binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a GEF affect GTP binding and downstream signaling? | CRISPR knockout of the GEF gene in cell lines |
| Does a specific phosphorylation site regulate GTP binding? | Point mutation (phosphomimetic/phosphodeficient) knock-in |
| Can a disease-associated mutation drive constitutive GTP binding? | Knock-in of the mutation in isogenic cell lines |
| Where and when does a GTPase bind GTP? | Tagged knock-in with a GTP-binding reporter (e.g., GFP-tagged GTPase) |
| What is the effect of overexpressing a GTPase on cellular behavior? | Overexpression via lentiviral transduction |
| Can we identify novel regulators of GTP binding? | CRISPR library screening with a GTP-binding reporter |
How to Study the positive regulation of GTP binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| GTPγS binding assay | Rate and extent of GTP binding | Quantify GEF activity in vitro |
| FRET-based GTPase sensor | Real-time GTP binding in live cells | Monitor spatiotemporal activation |
| Phosphoproteomics | Changes in phosphorylation | Identify signaling downstream of GTPases |
| RNA-seq | Transcriptional changes | Assess gene expression upon GTPase modulation |
| CRISPR knockout screen | Gene essentiality or reporter activation | Discover regulators of GTP binding |
| Immunofluorescence | Localization of GTPases | Study membrane recruitment |
| Co-immunoprecipitation | Protein-protein interactions | Identify GEFs and GAPs |
| Live-cell imaging | Dynamics of GTPase-positive structures | Analyze membrane tubules |
Biochemical GTP Binding Assays
Direct measurement of GTP binding can be performed using radioactive GTP (e.g., [35S]GTPγS) or fluorescent GTP analogs in pull-down or filter-binding assays. These methods quantify the rate and extent of GTP binding to purified proteins or cell lysates.
Live-Cell Imaging of GTPase Activity
Genetically encoded reporters, such as GFP-tagged GTPases or FRET-based sensors, allow real-time visualization of GTP binding in living cells. For example, anillin dynamics during cytokinesis can be monitored using fluorescent fusion proteins.
Omics Approaches
RNA-seq and proteomics can identify changes in gene expression and protein abundance upon modulation of GTP binding [2, 5]. Phosphoproteomics can reveal signaling networks downstream of GTPases.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens coupled with a GTP-binding readout can identify novel regulators of this process. Such screens have been used to uncover genes involved in membrane trafficking and signal transduction.
How CRISPR Can Be Used to Study GO:1904426 positive regulation of GTP binding
Knockout
CRISPR knockout of genes encoding GTPases or their regulators can abolish GTP binding and reveal loss-of-function phenotypes [1, 6]. For example, knocking out ANLN disrupts cytokinesis, and knocking out RAB7A impairs mitophagy [2, 6].
Point Mutation
Point mutations can be introduced to mimic disease-associated variants or to test the role of specific residues in GTP binding [1, 2]. For instance, the G12V mutation in HRAS locks it in the GTP-bound state, and phosphomimetic mutations in RAB7A affect its function [1, 2].
Knock-in
Knock-in of tagged or reporter versions of GTPases allows visualization and quantification of GTP binding in native contexts. For example, GFP knock-in of anillin enables live-cell imaging of its dynamics.
Overexpression
Overexpression of wild-type or mutant GTPases can increase GTP binding and downstream signaling, providing gain-of-function models [5, 8]. Overexpression of DRG2 stabilizes Rac1-positive tubules, and overexpression of Ral GTPases enhances membrane trafficking [5, 8].
How EDITGENE Supports positive regulation of GTP binding Research
Researchers studying positive regulation of GTP binding-related genes often need to determine whether a candidate gene is causally involved in the process, and CRISPR-based models are essential for this task.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of GTP binding research.
Frequently Asked Questions About positive regulation of GTP binding
What is positive regulation of GTP binding?
Positive regulation of GTP binding (GO:1904426) is any process that activates or increases the frequency, rate, or extent of GTP binding to a protein, often by promoting GDP-to-GTP exchange or inhibiting GTP hydrolysis.
What genes are involved in positive regulation of GTP binding?
Key genes include HRAS, RAB7A, DEP1, FlhF, DRG2, ANLN, GNL3, RALA, RALB, RHOA, RAC1, and heterotrimeric G-protein subunits such as GNAI1, GNAI2, GNAI3, GNAS, GNAQ, GNA11, and GNA12 [1, 2, 3, 4, 5, 6, 7, 8].
How is GTP binding regulated?
GTP binding is regulated by guanine nucleotide exchange factors (GEFs) that promote GTP loading, GTPase activating proteins (GAPs) that accelerate hydrolysis, and accessory proteins that stabilize the GTP-bound state [1, 2].
What diseases are associated with dysregulated GTP binding?
Dysregulated GTP binding is linked to cancer (e.g., RAS mutations), neurodegeneration (e.g., RAB7A in Parkinson's disease), developmental disorders (e.g., GNAS mutations), and infectious diseases (e.g., bacterial flagellar biogenesis) [1, 2, 3, 4].
What methods are used to study positive regulation of GTP binding?
Common methods include GTPγS binding assays, FRET-based sensors, live-cell imaging, phosphoproteomics, RNA-seq, and CRISPR screens [1, 2, 5, 6, 8].
Can CRISPR be used to study GTP binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect the causal roles of genes in GTP binding and downstream signaling [1, 2, 6, 8].
What is the role of GEFs in GTP binding?
GEFs catalyze the exchange of GDP for GTP, thereby positively regulating GTP binding and activating GTPases.
How does RAB7A regulate mitophagy?
RAB7A is a late endosomal GTPase that, when phosphorylated, coordinates Rubicon Homology protein regulation of Parkin-dependent mitophagy, a process critical for mitochondrial quality control.
What is the significance of DEP1 in plants?
DEP1 is a G-protein γ subunit that facilitates brassinosteroid signaling in rice via a MYB-bHLH-ARF module, influencing plant architecture and yield.
What is the role of DRG2 in cells?
DRG2 is required for stabilization of Rac1-positive membrane tubules, which are important for cell migration and membrane dynamics.
Conclusion
Positive regulation of GTP binding (GO:1904426) is a fundamental biological process that controls the activation of GTPases and other GTP-binding proteins, impacting signal transduction, membrane trafficking, cell division, and development [1, 8]. Its dysregulation is implicated in cancer, neurodegeneration, and developmental disorders, making it a key area of biomedical research [2, 5, 7]. Advances in CRISPR-based models and omics technologies are enabling researchers to dissect the precise mechanisms and identify therapeutic targets [1, 2, 6, 8]. EDITGENE offers comprehensive services to support these studies, from custom knockout and knock-in cell lines to CRISPR library screening and bioinformatics analysis.
References
- 1. Smith B et al.. 2009. Dual positive and negative regulation of GPCR signaling by GTP hydrolysis.. Cell Signal 21(7):1151-60 PMID: 19285552
- 2. Tudorica DA et al.. 2024. A RAB7A phosphoswitch coordinates Rubicon Homology protein regulation of Parkin-dependent mitophagy.. J Cell Biol 223(7) PMID: 38728007
- 3. Li S et al.. 2025. The G-protein γ subunit DEP1 facilitates brassinosteroid signaling in rice via a MYB-bHLH-ARF module.. Plant Cell 37(5) PMID: 40398925
- 4. Kojima S et al.. 2020. Regulation of the Single Polar Flagellar Biogenesis.. Biomolecules 10(4) PMID: 32244780
- 5. Mani M et al.. 2017. Developmentally regulated GTP-binding protein 2 is required for stabilization of Rac1-positive membrane tubules.. Biochem Biophys Res Commun 493(1):758-764 PMID: 28865956
- 6. Beaudet D et al.. 2020. Importin binding mediates the intramolecular regulation of anillin during cytokinesis.. Mol Biol Cell 31(11):1124-1139 PMID: 32238082
- 7. Huang M et al.. 2011. Reactive oxygen species regulate nucleostemin oligomerization and protein degradation.. J Biol Chem 286(13):11035-46 PMID: 21242306
- 8. van Dam EM et al.. 2006. Ral: mediator of membrane trafficking.. Int J Biochem Cell Biol 38(11):1841-7 PMID: 16781882
